Table 2.
Cold chain capacity, interviews with 96 health facility managers in 10 countries.
Does your facility have onsite cold chain capacity for vaccine storage? |
|||||||
---|---|---|---|---|---|---|---|
PAB < 90% | PAB ≥ 90% | Group 1 | Group 2 | Group 3 | Group 4 | Total | |
No n (%) | 3 (6.38) | 1 (2.4) | – | 4 (8.9) | 0 (0) | 0 (0) | 4 (4.2) |
Yes n (%) | 44 (93.62) | 41 (97.6) | – | 41 (91.1) | 33 (1 0 0) | 17 (1 0 0) | 91 (95.8) |
Total | 47 (1 0 0) | 42 (1 0 0) | – | 44 (1 0 0) | 33 (1 0 0) | 17 (1 0 0) | 95 (1 0 0) |
Fisher's exact | 0.62 | 0.046/0.009* | 0.293 | 1 | |||
Does your facility have a sufficient supply of TTCV? | |||||||
PAB < 90% | PAB ≥ 90% | Group 1 | Group 2 | Group 4 | Group 3 | Total | |
No n (%) | 2 (4.35) | 6 (14) | – | 6 (13.6) | 2 (6.06) | 0 (0) | 8 (9) |
Yes n (%) | 44 (95.65) | 37 (86) | – | 38 (86.4) | 31 (93.94) | 18 (1 0 0) | 87 (91) |
Total | 46 (1 0 0) | 43 (1 0 0) | – | 44 (1 0 0) | 33 (1 0 0) | 18 (1 0 0) | 95 (1 0 0) |
Fisher's exact | 0.149 | 0.139 | 0.710 | 0.345 | |||
Have you experienced any stock outs of TTCV at your facility? | |||||||
PAB < 90% | PAB ≥ 90% | Group 1 | Group 2 | Group 4 | Group 3 | Total | |
No n (%) | 41 (89.1) | 31 (72.1) | – | 32 (72.7) | 29 (87.88) | 17 (94.44) | 78 (82.1) |
Yes n (%) | 5 (10.9) | 12 (27.9) | – | 12 (27.3) | 4 (12.12) | 1 (5.56) | 17 (17.9) |
Total | 46 (1 0 0) | 43 (1 0 0) | – | 44 (1 0 0) | 33 (1 0 0) | 18 (1 0 0) | 95 (1 0 0) |
Fisher's exact | 0.059/0.131* | 0.033/0.133* | 0.401 | 0.180/0.092* |
Group 1: very limited potential (VLimP)
Group 2: Limited potential (LimP)
Group 3: Moderate potential (ModP)
Group 4: High potential (HighP)
p-value from generalized estimating equations